Article
Germline Testing for Patients With BRCA1/2 Mutations on Somatic Tumor Testing
8 Nov 2019
Abstract excerpt
Abstract Background The National Comprehensive Cancer Network (NCCN) recommends germline testing for pathogenic BRCA1/2 mutations identified by somatic tumor sequencing. The aim of this study was to explore whether patients at Stanford with somatic BRCA1/2 mutations were recommended germline testing in accordance with NCCN guidelines. Methods We retrospectively collected all Stanford patients with BRCA1/2...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
